Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
ChemoCentryx (CCXI) Gets Positive CHMP Opinion for Tavneos
12:24pm, Monday, 15'th Nov 2021
ChemoCentryx (CCXI) receives a positive recommendation from the CHMP for its lead drug Tavneos to treat two forms of ANCA-associated vasculitis.
ChemoCentryx (CCXI) Q3 Loss Narrower Than Expected, Sales Top
12:14pm, Wednesday, 10'th Nov 2021
ChemoCentryx (CCXI) posts narrower-than-expected loss for third-quarter 2021. The company's revenues for the quarter also beat estimates.
ChemoCentryx to Participate in Two Upcoming Investor Conferences
08:00am, Wednesday, 10'th Nov 2021
SAN CARLOS, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in two u
Big Pharma Is Going Holiday Shopping. Who's Next?
06:20am, Wednesday, 10'th Nov 2021
After an infusion of cash from COVID-19 treatments, many companies are on the lookout for acquisitions.
ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q3 2021 Results - Earnings Call Transcript
11:51pm, Tuesday, 09'th Nov 2021
ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q3 2021 Results - Earnings Call Transcript
Should You Buy ChemoCentryx (CCXI) Ahead of Earnings?
10:45am, Monday, 08'th Nov 2021
ChemoCentryx (CCXI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ChemoCentryx to Hold Third Quarter 2021 Financial Results Conference Call on Tuesday, November 9, 2021
08:30am, Tuesday, 02'nd Nov 2021
MOUNTAIN VIEW, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's third quarter 2021 financial results will be released after market close
ChemoCentryx (CCXI) Expected to Beat Earnings Estimates: Should You Buy?
04:06pm, Monday, 01'st Nov 2021
ChemoCentryx (CCXI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Biotech Stocks That Could Rise 90% or More, According to Wall Street
06:21am, Sunday, 17'th Oct 2021
These stocks are expected to put up big gains in a short amount of time.
Is It Too Late to Buy ChemoCentryx Stock?
07:18am, Thursday, 14'th Oct 2021
The stock surged after obtaining FDA approval for avacopan.
2 Super-Charged Growth Stocks to Buy Now
10:00am, Wednesday, 13'th Oct 2021
These two small drugmakers are poised for a long-winded growth spurt.
BZ Chart Of The Day: ChemoCentryx
11:43am, Monday, 11'th Oct 2021
There's an old saying on Wall Street that "gaps refill." It's true and it may be about to happen to shares of ChemoCentryx, Inc. (NASDAQ:CCXI).
CCXI Stock: Why It Increased Today
10:17am, Monday, 11'th Oct 2021
The stock price of ChemoCentryx Inc (NASDAQ: CCXI) increased by over 9% during intraday trading today. This is why it happened.
ChemoCentryx Appoints Rita I. Jain, M.D.
08:30am, Monday, 11'th Oct 2021
Appointment Brings More than 20 Years of Drug Development Experience as Company Launches First Product
Why ChemoCentryx Stock Skyrocketed Today
05:40pm, Friday, 08'th Oct 2021
Investors are excited about the biotech's game-changing new drug.
